Android-25 Side Effects
Generic name: methyltestosterone
Medically reviewed by Drugs.com. Last updated on Oct 10, 2024.
Note: This document provides detailed information about Android-25.
Applies to methyltestosterone: oral capsules, oral tablets Side Effects associated with methyltestosterone. Some dosage forms listed on this page may not apply specifically to the brand name Android-25.
Applies to methyltestosterone: oral capsules, oral tablets.
Side effects include:
Males: Gynecomastia, frequent or persistent penile erections.
Females: Amenorrhea, other menstrual irregularities, inhibition of gonadotropin secretion, virilization (e.g., deepening of the voice, clitoral enlargement).
For healthcare professionals
Applies to methyltestosterone: compounding powder, oral capsule, oral tablet.
General adverse events
The more commonly reported adverse effects of androgen therapy in males is gynecomastia and excessive frequency and duration of penile erections; in women, virilization including voice deepening and clitoral enlargement.[Ref]
Cardiovascular
- Frequency not reported: Edema with or without congestive heart failure, myocardial infarction, stroke
- Postmarketing reports: venous thromboembolic events, including deep vein thrombosis (DVT)[Ref]
Endocrine
Hepatic
- Rare (less than 0.1%): Peliosis hepatic
- Frequency not reported: Cholestatic jaundice, altered liver function[Ref]
Genitourinary
- Frequency not reported: Amenorrhea, menstrual irregularities, excessive frequency and duration of penile erections, oligospermia, increased or decreased libido[Ref]
Metabolic
- Frequency not reported: Retention of sodium, chloride, water, potassium, calcium and inorganic phosphates, increased serum cholesterol, hypercalcemia[Ref]
Dermatologic
Gastrointestinal
Musculoskeletal
- Frequency not reported: acceleration of bone maturation without producing compensatory gain in linear growth resulting in compromised adult stature[Ref]
Hematologic
- Frequency not reported: Suppression of clotting factors II, V, VII, and X; bleeding (in patients on concomitant anticoagulant therapy and polycythemia)[Ref]
Hypersensitivity
- Very rare (less than 0.01%): Anaphylactoid reactions[Ref]
Nervous system
Oncologic
- Rare (less than 0.1%): Hepatocellular neoplasms[Ref]
Respiratory
- Postmarketing reports: venous thromboembolic events, including pulmonary embolism[Ref]
Psychiatric
- Frequency not reported: Steroid abuse, anxiety, depression
References
1. (2022) "Product Information. MethylTESTOSTERone (methylTESTOSTERone)." Impax Generics
2. "Product Information. Android (methylTESTOSTERone)." ICN Pharmaceuticals Inc
More about Android-25 (methyltestosterone)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
Patient resources
Other brands
Professional resources
Other brands
Other formulations
Related treatment guides
Further information
Android-25 side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.